The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms. Through ...
PORTLAND, Ore (KOIN) – On behalf of our sponsors at Abbott, we’re learning about how a medical breakthrough is transforming the way we treat abnormal heart rhythms and one Boston mother’s story shows ...
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's growing pulsed field ablation and novel cardiac pacing portfolios Six-month ...
Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...
ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...
Pacemakers, relied upon by many patients with irregular heart rhythms, are not built for children. Scrambling up trees, hanging from monkey bars, and even the simple act of growing make the device ...
Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...
A wireless or leadless (without wires) pacemaker was implanted in a select group of children with irregular heart rhythms during a 5-year period (2016-2021). Smaller catheters that allow easier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results